Staurosporine derivatives for hypereosinophilic syndrome

Details for Australian Patent Application No. 2004244747 (hide)

Owner Novartis AG

Inventors Griffin, James Douglas; Gilliland, D. Gary

Agent Davies Collison Cave

Pub. Number AU-B-2004244747

PCT Pub. Number WO2004/108132

Priority 60/476,376 06.06.03 US

Filing date 4 June 2004

Wipo publication date 16 December 2004

Acceptance publication date 8 May 2008

International Classifications

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

G11B 5/48 (2006.01) Recording by magnetisation or demagnetisation of a record carrier - Disposition or mounting of heads relative to record carriers

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/108132 Priority application(s): WO2004/108132

8 May 2008 Application Accepted

  Published as AU-B-2004244747

4 September 2008 Standard Patent Sealed

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004244750-Method and device for extracting milk from animals

2004244740-Disposable injection syringe